Mark E. Dmytruk - Jan 3, 2025 Form 4 Insider Report for Ginkgo Bioworks Holdings, Inc. (DNA)

Role
Chief Financial Officer
Signature
/s/ Karen Tepichin, Attorney-in-Fact
Stock symbol
DNA
Transactions as of
Jan 3, 2025
Transactions value $
-$7,558
Form type
4
Date filed
1/8/2025, 05:01 PM
Previous filing
Dec 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DNA Class A Common Stock Options Exercise +450 +1.39% 32.8K Jan 3, 2025 Direct F1
transaction DNA Class A Common Stock Options Exercise +453 +1.38% 33.3K Jan 3, 2025 Direct F1
transaction DNA Class A Common Stock Options Exercise +572 +1.72% 33.9K Jan 3, 2025 Direct F1
transaction DNA Class A Common Stock Sale -$7.56K -645 -1.9% $11.72 33.2K Jan 6, 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DNA Restricted Stock Units Options Exercise -450 -7.65% 5.43K Jan 3, 2025 Class A Common Stock 450 Direct F1
transaction DNA Restricted Stock Units Options Exercise -453 -3.7% 11.8K Jan 3, 2025 Class A Common Stock 453 Direct F1, F3
transaction DNA Restricted Stock Units Options Exercise -572 -2.56% 21.8K Jan 3, 2025 Class A Common Stock 572 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
F2 Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction.
F3 The RSUs vest in 48 equal monthly installments, which began on April 1, 2023.
F4 The RSUs vest in 48 equal monthly installments, which began on April 1, 2024.

Remarks:

Chief Financial Officer